Phytomedicine
Volume 16, Issue 1 , Pages 72-84 , January 2009

Suspected hepatotoxicity by Cimicifugae racemosae rhizoma (black cohosh, root): Critical analysis and structured causality assessment

References 

  1. de Abajo FJ, Montero S, Madurga M, et al. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br. J. Clin. Pharmacol. 2004;58:71–80
  2. Adachi M, Saito H, Kobayashi H, Horie Y, Kato S, Yoshioka M, et al. Hepatic injury in 12 patients taking the herbal weight loss aids Chaso or Onshido. Ann. Intern. Med. 2003;139:488–492
  3. Bénichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J. Hepatol. 1990;11:272–276
  4. Bénichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs – II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J. Clin. Epidemiol. 1993;46:1331–1336
  5. Cohen, S.M., 2004a. Hepatitis associated with black cohosh: case 1. Workshop on the safety of black cohosh in clinical studies. In: Proceedings of the NIH, November 22, pp. 22–24.
  6. Cohen, S.M., 2004b. Hepatitis associated with black cohosh: case 2. Workshop on the safety of black cohosh in clinical studies. In: Proceedings of the NIH, November 22, p. 23–24.
  7. Cohen SM, O’Connor AM, Hart J, Merel N, Te HS. Autoimmune hepatitis associated with the use of black cohosh. Menopause. 2004;11:575–577
  8. Danan G, Bénichou C. Causality assessment of adverse reactions to drugs – I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J. Clin. Epidemiol. 1993;46:1323–1330
  9. Dunbar K, Solga SF. Black cohosh, safety, and public awareness. Liver Int. 2007;27:1017–1018
  10. Durazo FA, Lassman C, Han SHB, Saa S, Lee NP, Kawano M, et al. Fulminant liver failure due to usnic acid for weight loss. Am. J. Gastroenterol. 2004;99:950–952
  11. EMEA, 2006.Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (black cohosh, root). 〈www.emea.eu.int/pdfs/human/hmpc/26025806en.pdf#search=%22HMPC%20cimicifuga%20hepatotoxicity%22〉. Accessed 18 July.
  12. Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch. Surg. 2003;138:852–858
  13. Fimmel CJ, Guo L, Compans RW, Brunt EM, Hickman S, Perrillo RR, et al. A case of syncytial giant cell hepatitis with features of a paramyxoviral infection. Am. J. Gastro-Enterol. 1998;93:1931–1937
  14. Kaplowitz N. Causality assessment versus guilt-by-association in drug hepatotoxicity. Hepatology. 2001;33:308–310
  15. Levitsky J, Alli TA, Wisecarver J, Sorrell MF. Fulminant liver failure associated with the use of black cohosh. Dig. Dis. Sci. 2005;50:538–539
  16. Luzar B, Ferlan-Marolt V, Poljak M, Sojar V, Stanisavljevic D, Bukovac T. Makovic. Acute fatty liver of pregnancy – an underlying condition for herpes simplex type 2 fulminant hepatitis necessitating liver transplantation. Z. Gastroenterol. 2005;43:451–454
  17. Lynch CR, Folkers ME, Hutson WR. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transplant. 2006;12:989–992
  18. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N. Engl. J. Med. 2006;354:731–739
  19. O’Connor AM, Merel N, Te HS, Cohen SM. A case of autoimmune hepatitis associated with the use of black cohosh. Am. J. Gastroenterol. 2003;98(Suppl):5165
  20. Phillips MJ, Poucell S, Patterson J, Roberts EA, Doane FW, Petric M, et al. Syncytial giant-cell hepatitis, a subtype of hepatitis non-A non-B with paramyxoviral-like inclusions. Hepatology. 1988;8:1275
  21. Phillips MJ, Blendis LM, Poucell S, Patterson J, Petric M, Roberts PDE, et al. Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, as severe clinical course, and paramyxoviral features. N. Engl. J. Med. 1991;324:455–460
  22. Pinna AD, Rakela J, Demetris AJ, Fung JJ. Five cases of fulminant hepatitis due to herpes simplex virus in adults. Dig. Dis. Sci. 2002;47:750–754
  23. Pishvaian AC, Bahrain M, Lewis JH. Fatal varicella-zoster hepatitis presenting with severe abdominal pain: a case report and review of the literature. Dig. Dis. Sci. 2006;51:1221–1225
  24. Strom LE, 2006. Nebraska judgement of 8. September 2006. 〈www.ahpa.org/Portals/0/pdfs/06_0908_BlackCohosh_NebraskaDistrictCt.pdf〉.
  25. Teschke R, Gaus W, Loew D. Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine. 2003;10:440–446
  26. Velasco M, Llamas E, Guijarro-Rojas M, Ruiz-Yague M. Fulminant herpes hepatitis in a healthy adult. A treatable disorder?. J. Clin. Gastroenterol. 1999;28:386–389
  27. Watkins PB, Seeff LB. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology. 2006;43:618–631
  28. Willett KL, Roth RA, Walker L. Workshop overview: hepatotoxicity assessment for botanical dietary supplements. Toxicol. Sci. 2004;79:4–9
  29. Zimmerman HJ. Hepatotoxicity. Philadelphia: Lippincott Williams & Wilkins; 1999;

PII: S0944-7113(08)00173-6

doi: 10.1016/j.phymed.2008.09.009

Phytomedicine
Volume 16, Issue 1 , Pages 72-84 , January 2009

Article Tools

* Image Usage & Resolution